合計 50 件の最近のインサイダー取引記録が記録されています Akero Therapeutics, Inc. (AKRO), 内訳は 10 件の買い および 40 件の売り. インサイダー買い総額は $8.79M インサイダー売り総額は $8.67M.
最近活動のある主要インサイダーには Lamy Patrick, Gangloff Scott A., Cheng Andrew. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — AKRO
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-06-20 |
Lamy Patrick |
Senior VP, Commercial Strategy |
情報に基づく売り |
875 |
$54.59 |
$47.77K |
31,698 |
| 2025-06-18 |
Gangloff Scott A. |
Chief Technology Officer |
情報に基づく売り |
848 |
$54.84 |
$46.5K |
23,452 |
| 2025-06-18 |
Cheng Andrew |
President and CEO |
情報に基づく売り |
6,620 |
$54.84 |
$363.04K |
549,867 |
| 2025-06-18 |
White William Richard |
Chief Financial Officer |
情報に基づく売り |
1,634 |
$54.84 |
$89.61K |
57,521 |
| 2025-06-18 |
Yale Catriona |
Chief Development Officer |
情報に基づく売り |
1,633 |
$54.84 |
$89.55K |
90,598 |
| 2025-06-18 |
Rolph Timothy |
Chief Scientific Officer |
情報に基づく売り |
1,129 |
$54.84 |
$61.91K |
166,234 |
| 2025-06-18 |
Young Jonathan |
Chief Operating Officer |
情報に基づく売り |
1,453 |
$54.84 |
$79.68K |
196,594 |
| 2025-06-16 |
Yale Catriona |
Chief Development Officer |
オプション行使（売却） |
10,000 |
$21.10 |
$211K |
- |
| 2025-06-16 |
Lamy Patrick |
Senior VP, Commercial Strategy |
情報に基づく売り |
500 |
$55.09 |
$27.55K |
32,573 |
| 2025-06-10 |
Cheng Andrew |
President and CEO |
情報に基づく売り |
7,837 |
$53.99 |
$423.15K |
556,487 |
| 2025-06-10 |
White William Richard |
Chief Financial Officer |
情報に基づく売り |
2,804 |
$54.00 |
$151.4K |
59,155 |
| 2025-06-10 |
Yale Catriona |
Chief Development Officer |
情報に基づく売り |
2,803 |
$54.00 |
$151.35K |
92,231 |
| 2025-06-10 |
Rolph Timothy |
Chief Scientific Officer |
情報に基づく売り |
2,358 |
$54.00 |
$127.32K |
167,363 |
| 2025-06-10 |
Young Jonathan |
Chief Operating Officer |
情報に基づく売り |
2,493 |
$53.99 |
$134.6K |
198,047 |
| 2025-06-10 |
Lamy Patrick |
Senior VP, Commercial Strategy |
情報に基づく売り |
919 |
$54.00 |
$49.63K |
32,573 |
| 2025-06-06 |
Rolph Timothy |
Chief Scientific Officer |
オプション行使（売却） |
389 |
$21.10 |
$8.21K |
- |
| 2025-06-05 |
Rolph Timothy |
Chief Scientific Officer |
オプション行使（売却） |
12,500 |
$21.10 |
$263.75K |
389 |
| 2025-06-03 |
Harrison Seth Loring |
Director |
RSU 付与（制限付株式） |
9,398 |
- |
- |
145,699 |
| 2025-06-03 |
Iwicki Mark T |
Director |
RSU 付与（制限付株式） |
9,398 |
- |
- |
9,398 |
| 2025-06-03 |
Henderson Jane |
Director |
RSU 付与（制限付株式） |
9,398 |
- |
- |
9,398 |
| 2025-06-03 |
Graham G. Walmsley |
Director |
RSU 付与（制限付株式） |
9,398 |
- |
- |
11,566 |
| 2025-06-03 |
Heyman Tomas J. |
Director |
RSU 付与（制限付株式） |
9,398 |
- |
- |
9,398 |
| 2025-06-03 |
Xu Yuan |
Director |
RSU 付与（制限付株式） |
9,398 |
- |
- |
9,398 |
| 2025-06-03 |
Judy Chou |
Director |
RSU 付与（制限付株式） |
9,398 |
- |
- |
9,398 |
| 2025-06-02 |
Lamy Patrick |
Senior VP, Commercial Strategy |
情報に基づく売り |
100 |
$51.04 |
$5.1K |
33,492 |
| 2025-05-22 |
Lamy Patrick |
Senior VP, Commercial Strategy |
情報に基づく売り |
4,000 |
$50.00 |
$200K |
33,492 |
| 2025-05-15 |
Yale Catriona |
Chief Development Officer |
オプション行使（売却） |
10,000 |
$21.10 |
$211K |
10,000 |
| 2025-05-12 |
Cheng Andrew |
President and CEO |
情報に基づく売り |
22,800 |
$41.63 |
$949.26K |
594,324 |
| 2025-05-07 |
Lamy Patrick |
Senior VP, Commercial Strategy |
情報に基づく売り |
3,299 |
$42.76 |
$141.06K |
33,492 |
| 2025-05-06 |
Rolph Timothy |
Chief Scientific Officer |
オプション行使（売却） |
12,500 |
$21.10 |
$263.75K |
12,889 |
| 2025-04-24 |
Rolph Timothy |
Chief Scientific Officer |
オプション行使（売却） |
3,684 |
$21.10 |
$77.73K |
25,389 |
| 2025-04-15 |
Yale Catriona |
Chief Development Officer |
オプション行使（売却） |
9,073 |
$21.10 |
$191.44K |
20,000 |
| 2025-04-10 |
Cheng Andrew |
President and CEO |
情報に基づく売り |
30,000 |
$35.23 |
$1.06M |
624,324 |
| 2025-04-07 |
Rolph Timothy |
Chief Scientific Officer |
オプション行使（売却） |
6,250 |
$21.10 |
$131.88K |
28,718 |
| 2025-03-27 |
Graham G. Walmsley |
Director |
情報に基づく買い |
50,000 |
$43.55 |
$2.18M |
1,200,000 |
| 2025-03-26 |
Graham G. Walmsley |
Director |
情報に基づく買い |
58,691 |
$43.01 |
$2.52M |
1,150,000 |
| 2025-03-25 |
Graham G. Walmsley |
Director |
情報に基づく買い |
91,309 |
$44.75 |
$4.09M |
1,091,309 |
| 2025-03-17 |
Yale Catriona |
Chief Development Officer |
オプション行使（売却） |
10,000 |
$21.10 |
$211K |
- |
| 2025-03-12 |
Cheng Andrew |
President and CEO |
情報に基づく売り |
1,738 |
$44.88 |
$78K |
654,324 |
| 2025-03-12 |
White William Richard |
Chief Financial Officer |
情報に基づく売り |
676 |
$44.88 |
$30.34K |
61,959 |
| 2025-03-12 |
Yale Catriona |
Chief Development Officer |
情報に基づく売り |
614 |
$44.88 |
$27.56K |
95,034 |
| 2025-03-12 |
Rolph Timothy |
Chief Scientific Officer |
情報に基づく売り |
516 |
$44.88 |
$23.16K |
169,721 |
| 2025-03-12 |
Young Jonathan |
Chief Operating Officer |
情報に基づく売り |
607 |
$44.88 |
$27.24K |
200,540 |
| 2025-03-10 |
Cheng Andrew |
President and CEO |
情報に基づく売り |
1,216 |
$42.31 |
$51.45K |
656,062 |
| 2025-03-05 |
Rolph Timothy |
Chief Scientific Officer |
オプション行使（売却） |
12,500 |
$21.10 |
$263.75K |
34,968 |
| 2025-03-04 |
Young Jonathan |
Chief Operating Officer |
情報に基づく売り |
38,553 |
$45.07 |
$1.74M |
201,147 |
| 2025-03-03 |
Lamy Patrick |
Senior VP, Commercial Strategy |
情報に基づく売り |
1,000 |
$48.09 |
$48.09K |
33,492 |
| 2025-02-18 |
Yale Catriona |
Chief Development Officer |
オプション行使（売却） |
10,000 |
$21.10 |
$211K |
10,000 |
| 2025-02-10 |
Cheng Andrew |
President and CEO |
情報に基づく売り |
200 |
$55.81 |
$11.16K |
686,062 |
| 2025-02-05 |
Rolph Timothy |
Chief Scientific Officer |
オプション行使（売却） |
18,750 |
$21.10 |
$395.63K |
47,468 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
